Treatment of refractory angina in patients not suitable for revascularization
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://www.nature.com/articles/nrcardio.2013.200.pdf
Reference166 articles.
1. Jolicoeur, E. M. et al. Clinical and research issues regarding chronic advanced coronary artery disease: part I: contemporary and emerging therapies. Am. Heart J. 155, 418–434 (2008).
2. Jolicoeur, E. M. et al. Clinical and research issues regarding chronic advanced coronary artery disease part II: trial design, outcomes, and regulatory issues. Am. Heart J. 155, 435–444 (2008).
3. Mannheimer, C. et al. The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur. Heart J. 23, 355–370 (2002).
4. McGillion, M. et al. Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines. Can. J. Cardiol. 28 (2 Suppl.), S20–S41 (2012).
5. Jolicoeur, E. M. et al. Patients with coronary refractory artery disease unsuitable for revascularization: definition, general principles, and a classification. Can. J. Cardiol. 28 (Suppl.), S50–S59 (2012).
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coronary Sinus Reducer Therapy for Refractory Angina and its Role in Modern Interventional Practice: A Contemporary Review;Interventional Cardiology: Reviews, Research, Resources;2024-07-09
2. Clinical Development and Proof of Principle Testing of New Regenerative Vegf-D Therapy for Refractory Angina: Rationale and Design of the Phase 2 Regenheart Trial;2024
3. BMP2 gene transfer induces pericardial effusion and inflammatory response in the ischemic porcine myocardium;Frontiers in Cardiovascular Medicine;2023-11-03
4. Expanding the Paradigm for Cardiovascular Palliative Care;Circulation;2023-09-26
5. Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double‐blind placebo‐controlled trial (EMPT‐ANGINA Trial);Clinical Cardiology;2023-09-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3